Nonocclusive mesenteric ischemia in a patient on maintenance hemodialysis.
- Authors
- Han S.Y.; Kwon Y.J.; Shin J.H.; Pyo H.J.; Kim A.R.
- Issue Date
- 2000
- Keywords
- Nonocclusive mesenteric ischemia; dialysis; midodrine
- Citation
- The Korean journal of internal medicine, v.15, no.1, pp 81 - 84
- Pages
- 4
- Indexed
- SCOPUS
- Journal Title
- The Korean journal of internal medicine
- Volume
- 15
- Number
- 1
- Start Page
- 81
- End Page
- 84
- URI
- https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/23600
- DOI
- 10.3904/kjim.2000.15.1.81
- ISSN
- 1226-3303
2005-6648
- Abstract
- Nonocclusive mesenteric ischemia (NOMI) is known to occupy about 25% to 60% of intestinal infarction. NOMI has been reported to be responsible for 9% of the deaths in the dialysis population and the postulated causes of NOMI include intradialytic hypotension, atherosclerosis and medications, such as diuretics, digitalis and vasopressors. Clinical manifestations, such as fever, diarrhea and leukocytosis, are nonspecific, which makes early diagnosis of NOMI very difficult. Case: A 66-year-old woman on maintenance hemodialysis for 5 years was admitted with syncope, abdominal pain and chilly sensation. Since 7 days prior to admission, blood pressure on the supine position during hemodialysis had frequently fallen to 80/50 mmHg. Four days later, she complained of progressive abdominal pain. Rebound tenderness and leukocytosis (WBC 13900/mm3) with left shift were noted. Stool examination was positive for occult blood. Abdominal CT scan showed a distended gall bladder with sludge. Under the impression of acalculous cholecystitis, she was operated on. Surgical and pathologic findings of colon colon were compatible with NOMI. Because of recurrent intradialytic hypotension, we started midodrine 2.5 mg just before hemodialysis and increased the dose up to 7.5 mg. After midodrine therapy, blood pressure during dialysis became stable and the symptoms associated with hypotension did not recur. CONCLUSION: As NOMI may occur within several hours or days after an intradialytic hypotensive episode, abdominal pain should be carefully observed and NOMI should be considered as a differential diagnosis. In addition, we suggest that midodrine be considered to prevent intradialytic hypotensive episodes.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 2. Clinical Science > Department of Nephrology and Hypertension > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.